APT Pharmaceuticals

APT Pharmaceuticals, Inc. was founded to develop inhaled therapeutics for inflammatory diseases and transplantation. The company’s lead program was inhaled cyclosporine which it developed through a pivotal Phase III clinical trial.

Investors

• Research Corporation Technologies
• Charter Life Sciences
• Vivo Ventures
• Versant Ventures
• Great Point Partners
• Three Arch Partners
• InterWest Partners
• Pinnacle Ventures.

Inventors/Founders

B. Lauren Charous, M.D.
Allergy and Research Care Center
Milwaukee Medical Clinic